Discovery of key gene offers new hope in treating chronic myeloid leukemia
A key gene that could enhance the treatment success rates of chronic myeloid leukemia (CML) has been discovered by researchers.
Oct 7, 2024
0
34
Heterocyclic Compounds: News and Research on Imatinib Mesylate
MeSH tree: D03.383.742.349
Competition from 'skinny label' generics saved medicare billions, according to report
An analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that competition from these counterparts saved Medicare Part D nearly $15 billion from 2015 to 2021. Skinny labeling allows generic drug ...
May 3, 2024
0
61
Study finds drug company could save taxpayers millions on Medicare generic oncology drugs
The U.S. government could save taxpayers between $228 million and $2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban ...
Jun 8, 2023
0
51
Scientists discover a new way to prevent secondary breast cancer
Scientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep, forming incurable secondary tumors.
Mar 13, 2023
0
150
Countering pharma's expensive gaming of the drug patent system
Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...
Dec 6, 2022
0
59
Are drug companies the villain? New study questions claims of 'evergreening'
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
47
First-ever licencing deal struck for cancer drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
Oct 20, 2022
0
29
High magnetic field reduces side effects caused by anti-cancer drug imatinib
Researchers led by Prof. Zhang Xin at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CAS) combined the 9.4 T static magnetic field (SMF) with a commonly used anti-cancer drug imatinib mesylate ...
Oct 14, 2022
0
40
Swiss drugmaker Novartis to spin off generics unit Sandoz
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022
0
36
Chemotherapy drugs from 'rogue' online pharmacies could endanger leukemia patients
Patients seeking to purchase chemotherapy drugs online face a confusing array of websites, over half of which potentially operate unsafely or illegally, finds a new study in the July 2022 issue of JNCCN—Journal of the National ...
Jul 28, 2022
0
91
